Respiratory drug delivery systems

Respiratory infections represent a major global health problem. They are often treated by parenteral administrations of antimicrobials. Unfortunately, systemic therapies of high-dose antimicrobials can lead to severe adverse effects and this calls for a need to develop inhaled formulations that enable targeted drug delivery to the airways with minimal systemic drug exposure. Recent technological advances facilitate the development of inhaled anti-microbial therapies. Novel particle engineering and intelligent device design also make dry powder inhalers appealing for the delivery of high-dose antibiotics.


  • Track 1-1 Nasal & Pulmonary drug delivery
  • Track 2-2 Inhaled formulations for respiratory infections
  • Track 3-3 Formulation approaches and devices
  • Track 4-4 Current development in the evaluation methods of Pulmonary DDS
  • Track 5-5 Delivery devices

Related Conference of Pharmaceutical Sciences